Niezgoda, P.; Ostrowska, M.; Adamski, P.; Gajda, R.; Kubica, J.
Pretreatment with P2Y12 Receptor Inhibitors in Acute Coronary Syndromes—Is the Current Standpoint of ESC Experts Sufficiently Supported? J. Clin. Med. 2023, 12, 2374.
https://doi.org/10.3390/jcm12062374
AMA Style
Niezgoda P, Ostrowska M, Adamski P, Gajda R, Kubica J.
Pretreatment with P2Y12 Receptor Inhibitors in Acute Coronary Syndromes—Is the Current Standpoint of ESC Experts Sufficiently Supported? Journal of Clinical Medicine. 2023; 12(6):2374.
https://doi.org/10.3390/jcm12062374
Chicago/Turabian Style
Niezgoda, Piotr, Małgorzata Ostrowska, Piotr Adamski, Robert Gajda, and Jacek Kubica.
2023. "Pretreatment with P2Y12 Receptor Inhibitors in Acute Coronary Syndromes—Is the Current Standpoint of ESC Experts Sufficiently Supported?" Journal of Clinical Medicine 12, no. 6: 2374.
https://doi.org/10.3390/jcm12062374
APA Style
Niezgoda, P., Ostrowska, M., Adamski, P., Gajda, R., & Kubica, J.
(2023). Pretreatment with P2Y12 Receptor Inhibitors in Acute Coronary Syndromes—Is the Current Standpoint of ESC Experts Sufficiently Supported? Journal of Clinical Medicine, 12(6), 2374.
https://doi.org/10.3390/jcm12062374